Precision AQ

Molly Borchardt, PharmDVice President

Strategist and former access decision maker. Focus on specialty drugs, including medical and pharmacy specialty drug management from clinical programs to specialty network and provider reimbursement strategy. Expertise in specialty drug rebates, medical drug management and reimbursement, and utilization management.

Let's talk

Insights from Molly Borchardt, PharmD

Payer Challenges for Patient Access to Autologous Cell and Gene Therapies Image

Commercialization & Access | Article Payer Challenges for Patient Access to Autologous Cell and Gene Therapies

Improving Patient Access to Cell Therapy Through Decentralized Manufacturing Image

Commercialization & Access | Article Improving Patient Access to Cell Therapy Through Decentralized Manufacturing

Pros and Cons of Various Reimbursement Models for Cell and Gene Therapies Image

Commercialization & Access | Article Pros and Cons of Various Reimbursement Models for Cell and Gene Therapies

Securing Access & Reimbursement for Rare Disease Therapies Image

Commercialization & Access | Industry Brief Securing Access & Reimbursement for Rare Disease Therapies